🔮
Keep Stock Illuminati Free
100% independent. Zero paywalls. Zero subscriptions.
Your support keeps the data flowing.
Donate via PayPal
One-time or recurring — every dollar helps us add more data & features.
Real-time market data and insights.
| Date | Insider | Shares | Price |
|---|
| Date | Insider | Shares | Price |
|---|---|---|---|
| 2026-01-16 | EVNIN LUKE | -38,782 | $0.5400000214576721 |
| 2026-01-13 | EVNIN LUKE | -43,198 | $0.550000011920929 |
| 2026-01-15 | EVNIN LUKE | -37,413 | $0.550000011920929 |
| 2026-01-14 | EVNIN LUKE | -30,616 | $0.5699999928474426 |
| 2026-01-12 | EVNIN LUKE | -58,980 | $0.5699999928474426 |
| 2026-01-08 | EVNIN LUKE | -7,716 | $0.6299999952316284 |
| 2026-01-09 | EVNIN LUKE | -24,678 | $0.6100000143051147 |
| 2026-01-06 | EVNIN LUKE | -40,761 | $0.6499999761581421 |
| 2026-01-05 | EVNIN LUKE | -18,378 | $0.6399999856948853 |
| 2026-01-07 | EVNIN LUKE | -11,915 | $0.6399999856948853 |
| 2026-01-06 | EVNIN LUKE | -40,761 | $0.6499999761581421 |
| 2026-01-05 | EVNIN LUKE | -18,378 | $0.6399999856948853 |
| 2026-01-07 | EVNIN LUKE | -11,915 | $0.6399999856948853 |
| 2025-12-31 | EVNIN LUKE | -24,962 | $0.6200000047683716 |
| 2026-01-02 | EVNIN LUKE | -18,568 | $0.6299999952316284 |
| 2025-12-30 | EVNIN LUKE | -34,847 | $0.6100000143051147 |
| 2025-12-30 | EVNIN LUKE | -34,847 | $0.6100000143051147 |
| 2026-01-02 | EVNIN LUKE | -18,568 | $0.6299999952316284 |
| 2025-12-31 | EVNIN LUKE | -24,962 | $0.6200000047683716 |
| 2025-12-29 | EVNIN LUKE | -108,606 | $0.6100000143051147 |
| 2025-12-22 | EVNIN LUKE | -59,307 | $0.6899999976158142 |
| 2025-12-23 | EVNIN LUKE | -71,428 | $0.6299999952316284 |
| 2025-12-26 | EVNIN LUKE | -35,632 | $0.6299999952316284 |
| 2025-12-24 | EVNIN LUKE | -16,310 | $0.6499999761581421 |
| 2025-12-16 | EVNIN LUKE | -14,548 | $1.0499999523162842 |
| 2025-12-15 | EVNIN LUKE | -23,640 | $1.0700000524520874 |
| 2025-12-16 | EVNIN LUKE | -14,548 | $1.0499999523162842 |
| 2025-12-15 | EVNIN LUKE | -23,640 | $1.0700000524520874 |
| 2025-12-17 | EVNIN LUKE | -9,983 | $1.1399999856948853 |
| 2025-12-15 | EVNIN LUKE | -23,640 | $1.0700000524520874 |
| 2025-12-17 | EVNIN LUKE | -9,983 | $1.1399999856948853 |
| 2025-12-17 | EVNIN LUKE | -9,983 | $1.1399999856948853 |
| 2025-12-16 | EVNIN LUKE | -14,548 | $1.0499999523162842 |
| 2025-12-12 | EVNIN LUKE | -17,858 | $1.0800000429153442 |
| 2025-12-11 | EVNIN LUKE | -28,009 | $1.0700000524520874 |
| 2025-12-10 | EVNIN LUKE | -37,104 | $1.059999942779541 |
| 2025-12-11 | EVNIN LUKE | -28,009 | $1.0700000524520874 |
| 2025-12-10 | EVNIN LUKE | -37,104 | $1.059999942779541 |
| 2025-12-12 | EVNIN LUKE | -17,858 | $1.0800000429153442 |
| 2025-12-12 | EVNIN LUKE | -17,858 | $1.0800000429153442 |
| 2025-12-10 | EVNIN LUKE | -37,104 | $1.059999942779541 |
| 2025-12-11 | EVNIN LUKE | -28,009 | $1.0700000524520874 |
| 2025-12-09 | EVNIN LUKE | -44,570 | $1.0099999904632568 |
| 2025-12-05 | EVNIN LUKE | -16,568 | $0.9700000286102295 |
| 2025-12-09 | EVNIN LUKE | -44,570 | $1.0099999904632568 |
| 2025-12-08 | EVNIN LUKE | -34,041 | $0.9900000095367432 |
| 2025-12-05 | EVNIN LUKE | -16,568 | $0.9700000286102295 |
| 2025-12-09 | EVNIN LUKE | -44,570 | $1.0099999904632568 |
| 2025-12-05 | EVNIN LUKE | -16,568 | $0.9700000286102295 |
| 2025-12-08 | EVNIN LUKE | -34,041 | $0.9900000095367432 |
| 2025-12-08 | EVNIN LUKE | -34,041 | $0.9900000095367432 |
| 2025-12-02 | GADICKE ANSBERT | -59,277 | $0.8899999856948853 |
| 2025-12-02 | MPM BioImpact LLC | -59,277 | $0.8899999856948853 |
| 2025-12-04 | EVNIN LUKE | -53,416 | $0.9700000286102295 |
| 2025-12-03 | MPM ONCOLOGY INNOVATIONS FUND LP | -57,225 | $0.8700000047683716 |
| 2025-12-02 | MPM BioVentures 2014 LLC | -59,277 | $0.8899999856948853 |
| 2025-12-03 | GADICKE ANSBERT | -57,225 | $0.8700000047683716 |
| 2025-12-04 | MPM ASSET MANAGEMENT LLC | -83,230 | $0.9700000286102295 |
| 2025-12-02 | MPM Oncology Innovations Fund GP LLC | -59,277 | $0.8899999856948853 |
| 2025-12-02 | MPM ASSET MANAGEMENT LLC | -59,277 | $0.8899999856948853 |
| 2025-12-03 | MPM Oncology Innovations Fund GP LLC | -57,225 | $0.8700000047683716 |
| 2025-12-02 | MPM ONCOLOGY INNOVATIONS FUND LP | -59,277 | $0.8899999856948853 |
| 2025-12-03 | MPM BioVentures 2014 LLC | -57,225 | $0.8700000047683716 |
| 2025-12-04 | MPM Oncology Innovations Fund GP LLC | -83,230 | $0.9700000286102295 |
| 2025-12-02 | MPM ASSET MANAGEMENT LLC | -59,277 | $0.8899999856948853 |
| 2025-12-03 | EVNIN LUKE | -36,726 | $0.8700000047683716 |
| 2025-12-04 | MPM BioVentures 2014 GP LLC | -83,230 | $0.9700000286102295 |
| 2025-12-03 | MPM BioVentures 2014 GP LLC | -57,225 | $0.8700000047683716 |
| 2025-12-04 | MPM BioVentures 2014 LLC | -83,230 | $0.9700000286102295 |
| 2025-12-04 | MPM Asset Management Investors BV2014 LLC | -83,230 | $0.9700000286102295 |
| 2025-12-03 | Oncology Impact Fund (Cayman) Management L.P. | -57,225 | $0.8700000047683716 |
| 2025-12-04 | MPM BioVentures 2014 LLC | -83,230 | $0.9700000286102295 |
| 2025-12-04 | MPM BioVentures 2014 (B), L.P. | -83,230 | $0.9700000286102295 |
| 2025-12-03 | GADICKE ANSBERT | -57,225 | $0.8700000047683716 |
| 2025-12-02 | GADICKE ANSBERT | -59,277 | $0.8899999856948853 |
| 2025-12-03 | MPM ONCOLOGY INNOVATIONS FUND LP | -57,225 | $0.8700000047683716 |
| 2025-12-03 | Oncology Impact Fund (Cayman) Management L.P. | -57,225 | $0.8700000047683716 |
| 2025-12-02 | EVNIN LUKE | -38,043 | $0.8899999856948853 |
| 2025-12-02 | GADICKE ANSBERT | -59,277 | $0.8899999856948853 |
| 2025-12-03 | UBS Oncology Impact Fund L.P. | -57,225 | $0.8700000047683716 |
| 2025-12-04 | MPM BioVentures 2014, L.P. | -83,230 | $0.9700000286102295 |
| 2025-12-02 | EVNIN LUKE | -38,043 | $0.8899999856948853 |
| 2025-12-03 | MPM ASSET MANAGEMENT LLC | -57,225 | $0.8700000047683716 |
| 2025-12-02 | GADICKE ANSBERT | -59,277 | $0.8899999856948853 |
| 2025-12-03 | MPM ASSET MANAGEMENT LLC | -57,225 | $0.8700000047683716 |
| 2025-12-04 | MPM ASSET MANAGEMENT LLC | -83,230 | $0.9700000286102295 |
| 2025-12-03 | UBS Oncology Impact Fund L.P. | -57,225 | $0.8700000047683716 |
| 2025-12-02 | MPM ONCOLOGY INNOVATIONS FUND LP | -59,277 | $0.8899999856948853 |
| 2025-12-04 | MPM Oncology Innovations Fund GP LLC | -83,230 | $0.9700000286102295 |
| 2025-12-03 | MPM BioVentures 2014 (B), L.P. | -57,225 | $0.8700000047683716 |
| 2025-12-02 | Oncology Impact Fund (Cayman) Management L.P. | -59,277 | $0.8899999856948853 |
| 2025-12-04 | MPM Asset Management Investors BV2014 LLC | -83,230 | $0.9700000286102295 |
| 2025-12-04 | UBS Oncology Impact Fund L.P. | -83,230 | $0.9700000286102295 |
| 2025-12-03 | MPM Oncology Innovations Fund GP LLC | -57,225 | $0.8700000047683716 |
| 2025-12-02 | MPM Asset Management Investors BV2014 LLC | -59,277 | $0.8899999856948853 |
| 2025-12-02 | GADICKE ANSBERT | -59,277 | $0.8899999856948853 |
| 2025-12-02 | UBS Oncology Impact Fund L.P. | -59,277 | $0.8899999856948853 |
| 2025-12-04 | MPM ASSET MANAGEMENT LLC | -83,230 | $0.9700000286102295 |
| 2025-12-02 | Oncology Impact Fund (Cayman) Management L.P. | -59,277 | $0.8899999856948853 |
| 2025-12-02 | UBS Oncology Impact Fund L.P. | -59,277 | $0.8899999856948853 |
| 2025-12-03 | EVNIN LUKE | -36,726 | $0.8700000047683716 |
| 2025-12-02 | MPM ASSET MANAGEMENT LLC | -59,277 | $0.8899999856948853 |
| 2025-12-03 | MPM ASSET MANAGEMENT LLC | -57,225 | $0.8700000047683716 |
| 2025-12-02 | MPM Oncology Innovations Fund GP LLC | -59,277 | $0.8899999856948853 |
| 2025-12-04 | MPM Oncology Innovations Fund GP LLC | -83,230 | $0.9700000286102295 |
| 2025-12-04 | MPM ASSET MANAGEMENT LLC | -83,230 | $0.9700000286102295 |
| 2025-12-04 | MPM BioVentures 2014 (B), L.P. | -83,230 | $0.9700000286102295 |
| 2025-12-03 | GADICKE ANSBERT | -57,225 | $0.8700000047683716 |
| 2025-12-02 | MPM Oncology Innovations Fund GP LLC | -59,277 | $0.8899999856948853 |
| 2025-12-04 | MPM Asset Management Investors BV2014 LLC | -83,230 | $0.9700000286102295 |
| 2025-12-03 | MPM Asset Management Investors BV2014 LLC | -57,225 | $0.8700000047683716 |
| 2025-12-03 | MPM BioVentures 2014, L.P. | -57,225 | $0.8700000047683716 |
| 2025-12-02 | MPM BioVentures 2014 GP LLC | -59,277 | $0.8899999856948853 |
| 2025-12-02 | MPM BioVentures 2014, L.P. | -59,277 | $0.8899999856948853 |
| 2025-12-04 | MPM BioImpact LLC | -83,230 | $0.9700000286102295 |
| 2025-12-04 | UBS Oncology Impact Fund L.P. | -83,230 | $0.9700000286102295 |
| 2025-12-03 | MPM Oncology Innovations Fund GP LLC | -57,225 | $0.8700000047683716 |
| 2025-12-03 | UBS Oncology Impact Fund L.P. | -57,225 | $0.8700000047683716 |
| 2025-12-03 | MPM BioVentures 2014 GP LLC | -57,225 | $0.8700000047683716 |
| 2025-12-03 | GADICKE ANSBERT | -57,225 | $0.8700000047683716 |
| 2025-12-04 | MPM BioVentures 2014 GP LLC | -83,230 | $0.9700000286102295 |
| 2025-12-02 | MPM Oncology Innovations Fund GP LLC | -59,277 | $0.8899999856948853 |
| 2025-12-03 | MPM ONCOLOGY INNOVATIONS FUND LP | -57,225 | $0.8700000047683716 |
| 2025-12-04 | UBS Oncology Impact Fund L.P. | -83,230 | $0.9700000286102295 |
| 2025-12-02 | UBS Oncology Impact Fund L.P. | -59,277 | $0.8899999856948853 |
| 2025-12-04 | MPM ASSET MANAGEMENT LLC | -83,230 | $0.9700000286102295 |
| 2025-12-03 | UBS Oncology Impact Fund L.P. | -57,225 | $0.8700000047683716 |
| 2025-12-04 | Oncology Impact Fund (Cayman) Management L.P. | -83,230 | $0.9700000286102295 |
| 2025-12-03 | Oncology Impact Fund (Cayman) Management L.P. | -57,225 | $0.8700000047683716 |
| 2025-12-02 | Oncology Impact Fund (Cayman) Management L.P. | -59,277 | $0.8899999856948853 |
| 2025-12-04 | Oncology Impact Fund (Cayman) Management L.P. | -83,230 | $0.9700000286102295 |
| 2025-12-02 | MPM BioVentures 2014 GP LLC | -59,277 | $0.8899999856948853 |
| 2025-12-02 | MPM BioImpact LLC | -59,277 | $0.8899999856948853 |
| 2025-12-02 | MPM BioVentures 2014 (B), L.P. | -59,277 | $0.8899999856948853 |
| 2025-12-04 | MPM ONCOLOGY INNOVATIONS FUND LP | -83,230 | $0.9700000286102295 |
| 2025-12-04 | UBS Oncology Impact Fund L.P. | -83,230 | $0.9700000286102295 |
| 2025-12-03 | MPM ASSET MANAGEMENT LLC | -57,225 | $0.8700000047683716 |
| 2025-12-02 | UBS Oncology Impact Fund L.P. | -59,277 | $0.8899999856948853 |
| 2025-12-03 | MPM Asset Management Investors BV2014 LLC | -57,225 | $0.8700000047683716 |
| 2025-12-02 | MPM Asset Management Investors BV2014 LLC | -59,277 | $0.8899999856948853 |
| 2025-12-04 | MPM BioVentures 2014, L.P. | -83,230 | $0.9700000286102295 |
| 2025-12-02 | MPM ASSET MANAGEMENT LLC | -59,277 | $0.8899999856948853 |
| 2025-12-02 | Oncology Impact Fund (Cayman) Management L.P. | -59,277 | $0.8899999856948853 |
| 2025-12-04 | MPM Asset Management Investors BV2014 LLC | -83,230 | $0.9700000286102295 |
| 2025-12-02 | UBS Oncology Impact Fund L.P. | -59,277 | $0.8899999856948853 |
| 2025-12-02 | MPM Oncology Innovations Fund GP LLC | -59,277 | $0.8899999856948853 |
| 2025-12-03 | MPM BioVentures 2014 LLC | -57,225 | $0.8700000047683716 |
| 2025-12-03 | MPM BioVentures 2014, L.P. | -57,225 | $0.8700000047683716 |
| 2025-12-03 | MPM BioVentures 2014 GP LLC | -57,225 | $0.8700000047683716 |
| 2025-12-02 | MPM BioVentures 2014 GP LLC | -59,277 | $0.8899999856948853 |
| 2025-12-04 | MPM BioVentures 2014 (B), L.P. | -83,230 | $0.9700000286102295 |
| 2025-12-04 | MPM BioVentures 2014 GP LLC | -83,230 | $0.9700000286102295 |
| 2025-12-03 | Oncology Impact Fund (Cayman) Management L.P. | -57,225 | $0.8700000047683716 |
| 2025-12-03 | Oncology Impact Fund (Cayman) Management L.P. | -57,225 | $0.8700000047683716 |
| 2025-12-04 | MPM Asset Management Investors BV2014 LLC | -83,230 | $0.9700000286102295 |
| 2025-12-04 | MPM BioVentures 2014 (B), L.P. | -83,230 | $0.9700000286102295 |
| 2025-12-04 | MPM ASSET MANAGEMENT LLC | -83,230 | $0.9700000286102295 |
| 2025-12-03 | MPM BioVentures 2014, L.P. | -57,225 | $0.8700000047683716 |
| 2025-12-04 | MPM BioImpact LLC | -83,230 | $0.9700000286102295 |
| 2025-12-02 | MPM BioImpact LLC | -59,277 | $0.8899999856948853 |
| 2025-12-02 | GADICKE ANSBERT | -59,277 | $0.8899999856948853 |
| 2025-12-03 | GADICKE ANSBERT | -57,225 | $0.8700000047683716 |
| 2025-12-03 | Oncology Impact Fund (Cayman) Management L.P. | -57,225 | $0.8700000047683716 |
| 2025-12-03 | MPM BioImpact LLC | -57,225 | $0.8700000047683716 |
| 2025-12-02 | Oncology Impact Fund (Cayman) Management L.P. | -59,277 | $0.8899999856948853 |
| 2025-12-04 | GADICKE ANSBERT | -83,230 | $0.9700000286102295 |
| 2025-12-03 | MPM ASSET MANAGEMENT LLC | -57,225 | $0.8700000047683716 |
| 2025-12-04 | GADICKE ANSBERT | -83,230 | $0.9700000286102295 |
| 2025-12-03 | MPM BioImpact LLC | -57,225 | $0.8700000047683716 |
| 2025-12-03 | MPM ONCOLOGY INNOVATIONS FUND LP | -57,225 | $0.8700000047683716 |
| 2025-12-04 | MPM ONCOLOGY INNOVATIONS FUND LP | -83,230 | $0.9700000286102295 |
| 2025-12-04 | UBS Oncology Impact Fund L.P. | -83,230 | $0.9700000286102295 |
| 2025-12-04 | MPM ONCOLOGY INNOVATIONS FUND LP | -83,230 | $0.9700000286102295 |
| 2025-12-02 | MPM BioImpact LLC | -59,277 | $0.8899999856948853 |
| 2025-12-02 | MPM BioVentures 2014 (B), L.P. | -59,277 | $0.8899999856948853 |
| 2025-12-02 | MPM Asset Management Investors BV2014 LLC | -59,277 | $0.8899999856948853 |
| 2025-12-03 | MPM BioVentures 2014 (B), L.P. | -57,225 | $0.8700000047683716 |
| 2025-12-02 | MPM BioVentures 2014, L.P. | -59,277 | $0.8899999856948853 |
| 2025-12-03 | MPM BioVentures 2014, L.P. | -57,225 | $0.8700000047683716 |
| 2025-12-02 | MPM BioVentures 2014 LLC | -59,277 | $0.8899999856948853 |
| 2025-12-02 | MPM Asset Management Investors BV2014 LLC | -59,277 | $0.8899999856948853 |
| 2025-12-02 | MPM BioVentures 2014 GP LLC | -59,277 | $0.8899999856948853 |
| 2025-12-04 | MPM BioVentures 2014, L.P. | -83,230 | $0.9700000286102295 |
| 2025-12-03 | MPM BioVentures 2014 LLC | -57,225 | $0.8700000047683716 |
| 2025-12-02 | MPM BioVentures 2014 (B), L.P. | -59,277 | $0.8899999856948853 |
| 2025-12-03 | MPM Oncology Innovations Fund GP LLC | -57,225 | $0.8700000047683716 |
| 2025-12-02 | MPM ASSET MANAGEMENT LLC | -59,277 | $0.8899999856948853 |
| 2025-12-04 | Oncology Impact Fund (Cayman) Management L.P. | -83,230 | $0.9700000286102295 |
| 2025-12-04 | GADICKE ANSBERT | -83,230 | $0.9700000286102295 |
| 2025-12-03 | MPM BioImpact LLC | -57,225 | $0.8700000047683716 |
| 2025-12-02 | MPM Asset Management Investors BV2014 LLC | -59,277 | $0.8899999856948853 |
| 2025-12-03 | MPM Asset Management Investors BV2014 LLC | -57,225 | $0.8700000047683716 |
| 2025-12-04 | MPM BioVentures 2014 LLC | -83,230 | $0.9700000286102295 |
| 2025-12-04 | MPM BioVentures 2014, L.P. | -83,230 | $0.9700000286102295 |
| 2025-12-04 | MPM BioVentures 2014 GP LLC | -83,230 | $0.9700000286102295 |
| 2025-12-03 | MPM BioVentures 2014 LLC | -57,225 | $0.8700000047683716 |
| 2025-12-02 | MPM Asset Management Investors BV2014 LLC | -59,277 | $0.8899999856948853 |
| 2025-12-02 | UBS Oncology Impact Fund L.P. | -59,277 | $0.8899999856948853 |
| 2025-12-03 | MPM BioVentures 2014 GP LLC | -57,225 | $0.8700000047683716 |
| 2025-12-04 | MPM Asset Management Investors BV2014 LLC | -83,230 | $0.9700000286102295 |
| 2025-12-04 | EVNIN LUKE | -53,416 | $0.9700000286102295 |
| 2025-12-02 | MPM ONCOLOGY INNOVATIONS FUND LP | -59,277 | $0.8899999856948853 |
| 2025-12-04 | MPM BioVentures 2014, L.P. | -83,230 | $0.9700000286102295 |
| 2025-12-02 | MPM BioImpact LLC | -59,277 | $0.8899999856948853 |
| 2025-12-03 | GADICKE ANSBERT | -57,225 | $0.8700000047683716 |
| 2025-12-02 | MPM Oncology Innovations Fund GP LLC | -59,277 | $0.8899999856948853 |
| 2025-12-04 | MPM ASSET MANAGEMENT LLC | -83,230 | $0.9700000286102295 |
| 2025-12-04 | MPM BioImpact LLC | -83,230 | $0.9700000286102295 |
| 2025-12-02 | MPM BioVentures 2014, L.P. | -59,277 | $0.8899999856948853 |
| 2025-12-04 | UBS Oncology Impact Fund L.P. | -83,230 | $0.9700000286102295 |
| 2025-12-04 | MPM ONCOLOGY INNOVATIONS FUND LP | -83,230 | $0.9700000286102295 |
| 2025-12-04 | MPM BioImpact LLC | -83,230 | $0.9700000286102295 |
| 2025-12-04 | MPM BioVentures 2014 GP LLC | -83,230 | $0.9700000286102295 |
| 2025-12-02 | MPM ONCOLOGY INNOVATIONS FUND LP | -59,277 | $0.8899999856948853 |
| 2025-12-04 | MPM Oncology Innovations Fund GP LLC | -83,230 | $0.9700000286102295 |
| 2025-12-03 | MPM Asset Management Investors BV2014 LLC | -57,225 | $0.8700000047683716 |
| 2025-12-04 | Oncology Impact Fund (Cayman) Management L.P. | -83,230 | $0.9700000286102295 |
| 2025-12-02 | MPM BioVentures 2014 (B), L.P. | -59,277 | $0.8899999856948853 |
| 2025-12-04 | MPM BioVentures 2014 LLC | -83,230 | $0.9700000286102295 |
| 2025-12-03 | MPM Asset Management Investors BV2014 LLC | -57,225 | $0.8700000047683716 |
| 2025-12-04 | MPM BioVentures 2014 GP LLC | -83,230 | $0.9700000286102295 |
| 2025-12-03 | MPM BioVentures 2014 LLC | -57,225 | $0.8700000047683716 |
| 2025-12-04 | MPM BioImpact LLC | -83,230 | $0.9700000286102295 |
| 2025-12-03 | MPM BioVentures 2014 GP LLC | -57,225 | $0.8700000047683716 |
| 2025-12-03 | MPM Oncology Innovations Fund GP LLC | -57,225 | $0.8700000047683716 |
| 2025-12-03 | MPM BioVentures 2014 GP LLC | -57,225 | $0.8700000047683716 |
| 2025-12-02 | MPM ASSET MANAGEMENT LLC | -59,277 | $0.8899999856948853 |
| 2025-12-03 | MPM BioImpact LLC | -57,225 | $0.8700000047683716 |
| 2025-12-02 | MPM BioVentures 2014 LLC | -59,277 | $0.8899999856948853 |
| 2025-12-02 | MPM BioVentures 2014 (B), L.P. | -59,277 | $0.8899999856948853 |
| 2025-12-04 | MPM ONCOLOGY INNOVATIONS FUND LP | -83,230 | $0.9700000286102295 |
| 2025-12-02 | MPM ONCOLOGY INNOVATIONS FUND LP | -59,277 | $0.8899999856948853 |
| 2025-12-04 | MPM BioImpact LLC | -83,230 | $0.9700000286102295 |
| 2025-12-04 | Oncology Impact Fund (Cayman) Management L.P. | -83,230 | $0.9700000286102295 |
| 2025-12-04 | GADICKE ANSBERT | -83,230 | $0.9700000286102295 |
| 2025-12-03 | MPM ASSET MANAGEMENT LLC | -57,225 | $0.8700000047683716 |
| 2025-12-02 | MPM BioVentures 2014 LLC | -59,277 | $0.8899999856948853 |
| 2025-12-03 | Oncology Impact Fund (Cayman) Management L.P. | -57,225 | $0.8700000047683716 |
| 2025-12-03 | MPM BioImpact LLC | -57,225 | $0.8700000047683716 |
| 2025-12-03 | MPM ONCOLOGY INNOVATIONS FUND LP | -57,225 | $0.8700000047683716 |
| 2025-12-03 | MPM BioVentures 2014 LLC | -57,225 | $0.8700000047683716 |
| 2025-12-03 | MPM BioVentures 2014 (B), L.P. | -57,225 | $0.8700000047683716 |
| 2025-12-03 | MPM Asset Management Investors BV2014 LLC | -57,225 | $0.8700000047683716 |
| 2025-12-04 | MPM BioVentures 2014 LLC | -83,230 | $0.9700000286102295 |
| 2025-12-02 | MPM ONCOLOGY INNOVATIONS FUND LP | -59,277 | $0.8899999856948853 |
| 2025-12-02 | MPM BioImpact LLC | -59,277 | $0.8899999856948853 |
| 2025-12-02 | MPM BioVentures 2014 GP LLC | -59,277 | $0.8899999856948853 |
| 2025-12-03 | MPM BioImpact LLC | -57,225 | $0.8700000047683716 |
| 2025-12-04 | MPM ONCOLOGY INNOVATIONS FUND LP | -83,230 | $0.9700000286102295 |
| 2025-12-04 | GADICKE ANSBERT | -83,230 | $0.9700000286102295 |
| 2025-12-04 | MPM BioImpact LLC | -83,230 | $0.9700000286102295 |
| 2025-12-04 | Oncology Impact Fund (Cayman) Management L.P. | -83,230 | $0.9700000286102295 |
| 2025-12-03 | UBS Oncology Impact Fund L.P. | -57,225 | $0.8700000047683716 |
| 2025-12-04 | MPM Oncology Innovations Fund GP LLC | -83,230 | $0.9700000286102295 |
| 2025-12-02 | MPM Asset Management Investors BV2014 LLC | -59,277 | $0.8899999856948853 |
| 2025-12-03 | MPM Oncology Innovations Fund GP LLC | -57,225 | $0.8700000047683716 |
| 2025-12-03 | Oncology Impact Fund (Cayman) Management L.P. | -57,225 | $0.8700000047683716 |
| 2025-12-04 | GADICKE ANSBERT | -83,230 | $0.9700000286102295 |
| 2025-12-04 | UBS Oncology Impact Fund L.P. | -83,230 | $0.9700000286102295 |
| 2025-12-03 | MPM BioVentures 2014, L.P. | -57,225 | $0.8700000047683716 |
| 2025-12-03 | MPM BioImpact LLC | -57,225 | $0.8700000047683716 |
| 2025-12-03 | MPM ASSET MANAGEMENT LLC | -57,225 | $0.8700000047683716 |
| 2025-12-02 | MPM BioImpact LLC | -59,277 | $0.8899999856948853 |
| 2025-12-04 | UBS Oncology Impact Fund L.P. | -83,230 | $0.9700000286102295 |
| 2025-12-03 | MPM ONCOLOGY INNOVATIONS FUND LP | -57,225 | $0.8700000047683716 |
| 2025-12-03 | UBS Oncology Impact Fund L.P. | -57,225 | $0.8700000047683716 |
| 2025-12-04 | MPM ONCOLOGY INNOVATIONS FUND LP | -83,230 | $0.9700000286102295 |
| 2025-12-02 | MPM BioVentures 2014, L.P. | -59,277 | $0.8899999856948853 |
| 2025-12-02 | MPM BioVentures 2014 (B), L.P. | -59,277 | $0.8899999856948853 |
| 2025-12-02 | MPM BioVentures 2014 LLC | -59,277 | $0.8899999856948853 |
| 2025-12-04 | MPM ONCOLOGY INNOVATIONS FUND LP | -83,230 | $0.9700000286102295 |
| 2025-12-03 | EVNIN LUKE | -36,726 | $0.8700000047683716 |
| 2025-12-03 | MPM Oncology Innovations Fund GP LLC | -57,225 | $0.8700000047683716 |
| 2025-12-04 | MPM ASSET MANAGEMENT LLC | -83,230 | $0.9700000286102295 |
| 2025-12-02 | EVNIN LUKE | -38,043 | $0.8899999856948853 |
| 2025-12-02 | MPM Oncology Innovations Fund GP LLC | -59,277 | $0.8899999856948853 |
| 2025-12-04 | MPM BioVentures 2014 (B), L.P. | -83,230 | $0.9700000286102295 |
| 2025-12-04 | MPM BioVentures 2014, L.P. | -83,230 | $0.9700000286102295 |
| 2025-12-04 | EVNIN LUKE | -53,416 | $0.9700000286102295 |
| 2025-12-02 | Oncology Impact Fund (Cayman) Management L.P. | -59,277 | $0.8899999856948853 |
| 2025-12-04 | GADICKE ANSBERT | -83,230 | $0.9700000286102295 |
| 2025-12-04 | MPM Asset Management Investors BV2014 LLC | -83,230 | $0.9700000286102295 |
| 2025-12-03 | MPM ASSET MANAGEMENT LLC | -57,225 | $0.8700000047683716 |
| 2025-12-02 | MPM ASSET MANAGEMENT LLC | -59,277 | $0.8899999856948853 |
| 2025-12-02 | GADICKE ANSBERT | -59,277 | $0.8899999856948853 |
| 2025-12-04 | MPM Oncology Innovations Fund GP LLC | -83,230 | $0.9700000286102295 |
| 2025-12-04 | MPM Oncology Innovations Fund GP LLC | -83,230 | $0.9700000286102295 |
| 2025-12-02 | MPM Oncology Innovations Fund GP LLC | -59,277 | $0.8899999856948853 |
| 2025-12-03 | MPM BioVentures 2014, L.P. | -57,225 | $0.8700000047683716 |
| 2025-12-03 | MPM BioVentures 2014 (B), L.P. | -57,225 | $0.8700000047683716 |
| 2025-12-02 | MPM ASSET MANAGEMENT LLC | -59,277 | $0.8899999856948853 |
| 2025-12-03 | MPM Asset Management Investors BV2014 LLC | -57,225 | $0.8700000047683716 |
| 2025-12-02 | MPM ONCOLOGY INNOVATIONS FUND LP | -59,277 | $0.8899999856948853 |
| 2025-12-04 | MPM BioVentures 2014 (B), L.P. | -83,230 | $0.9700000286102295 |
| 2025-12-04 | Oncology Impact Fund (Cayman) Management L.P. | -83,230 | $0.9700000286102295 |
| 2025-12-02 | MPM BioVentures 2014, L.P. | -59,277 | $0.8899999856948853 |
| 2025-12-04 | MPM BioImpact LLC | -83,230 | $0.9700000286102295 |
| 2025-12-02 | MPM BioVentures 2014 LLC | -59,277 | $0.8899999856948853 |
| 2025-12-04 | Oncology Impact Fund (Cayman) Management L.P. | -83,230 | $0.9700000286102295 |
| 2025-12-03 | MPM BioImpact LLC | -57,225 | $0.8700000047683716 |
| 2025-12-03 | MPM BioVentures 2014 (B), L.P. | -57,225 | $0.8700000047683716 |
| 2025-12-03 | MPM BioVentures 2014 (B), L.P. | -57,225 | $0.8700000047683716 |
| 2025-12-02 | UBS Oncology Impact Fund L.P. | -59,277 | $0.8899999856948853 |
| 2025-12-02 | MPM BioImpact LLC | -59,277 | $0.8899999856948853 |
| 2025-12-04 | MPM ASSET MANAGEMENT LLC | -83,230 | $0.9700000286102295 |
| 2025-12-04 | MPM BioVentures 2014 LLC | -83,230 | $0.9700000286102295 |
| 2025-12-03 | GADICKE ANSBERT | -57,225 | $0.8700000047683716 |
| 2025-12-03 | MPM ASSET MANAGEMENT LLC | -57,225 | $0.8700000047683716 |
| 2025-12-03 | UBS Oncology Impact Fund L.P. | -57,225 | $0.8700000047683716 |
| 2025-12-03 | GADICKE ANSBERT | -57,225 | $0.8700000047683716 |
| 2025-12-02 | GADICKE ANSBERT | -59,277 | $0.8899999856948853 |
| 2025-12-02 | Oncology Impact Fund (Cayman) Management L.P. | -59,277 | $0.8899999856948853 |
| 2025-12-04 | GADICKE ANSBERT | -83,230 | $0.9700000286102295 |
| 2025-12-04 | MPM Oncology Innovations Fund GP LLC | -83,230 | $0.9700000286102295 |
| 2025-12-02 | MPM BioVentures 2014 GP LLC | -59,277 | $0.8899999856948853 |
| 2025-12-02 | UBS Oncology Impact Fund L.P. | -59,277 | $0.8899999856948853 |
| 2025-12-02 | MPM ONCOLOGY INNOVATIONS FUND LP | -59,277 | $0.8899999856948853 |
| 2025-12-03 | MPM ONCOLOGY INNOVATIONS FUND LP | -57,225 | $0.8700000047683716 |
| 2025-12-03 | UBS Oncology Impact Fund L.P. | -57,225 | $0.8700000047683716 |
| 2025-12-03 | MPM Oncology Innovations Fund GP LLC | -57,225 | $0.8700000047683716 |
| 2025-12-02 | Oncology Impact Fund (Cayman) Management L.P. | -59,277 | $0.8899999856948853 |
| 2025-12-02 | MPM ASSET MANAGEMENT LLC | -59,277 | $0.8899999856948853 |
| 2025-12-03 | MPM ONCOLOGY INNOVATIONS FUND LP | -57,225 | $0.8700000047683716 |
| 2025-12-02 | MPM BioVentures 2014, L.P. | -59,277 | $0.8899999856948853 |
| 2025-11-28 | MPM Asset Management Investors BV2014 LLC | -20,277 | $0.9900000095367432 |
| 2025-11-26 | GADICKE ANSBERT | -60,733 | $0.9800000190734863 |
| 2025-12-01 | MPM Asset Management Investors BV2014 LLC | -60,917 | $0.9399999976158142 |
| 2025-11-26 | MPM ONCOLOGY INNOVATIONS FUND LP | -60,733 | $0.9800000190734863 |
| 2025-11-26 | MPM Asset Management Investors BV2014 LLC | -60,733 | $0.9800000190734863 |
| 2025-11-26 | MPM ASSET MANAGEMENT LLC | -60,733 | $0.9800000190734863 |
| 2025-11-26 | UBS Oncology Impact Fund L.P. | -60,733 | $0.9800000190734863 |
| 2025-12-01 | MPM Asset Management Investors BV2014 LLC | -60,917 | $0.9399999976158142 |
| 2025-12-01 | Oncology Impact Fund (Cayman) Management L.P. | -60,917 | $0.9399999976158142 |
| 2025-12-01 | MPM ASSET MANAGEMENT LLC | -60,917 | $0.9399999976158142 |
| 2025-12-01 | MPM ONCOLOGY INNOVATIONS FUND LP | -60,917 | $0.9399999976158142 |
| 2025-11-26 | EVNIN LUKE | -38,978 | $0.9800000190734863 |
| 2025-12-01 | UBS Oncology Impact Fund L.P. | -60,917 | $0.9399999976158142 |
| 2025-12-01 | MPM BioVentures 2014 GP LLC | -60,917 | $0.9399999976158142 |
| 2025-12-01 | MPM BioVentures 2014, L.P. | -60,917 | $0.9399999976158142 |
| 2025-11-28 | MPM Oncology Innovations Fund GP LLC | -20,277 | $0.9900000095367432 |
| 2025-12-01 | MPM BioVentures 2014 (B), L.P. | -60,917 | $0.9399999976158142 |
| 2025-12-01 | MPM BioVentures 2014 LLC | -60,917 | $0.9399999976158142 |
| 2025-11-28 | MPM ASSET MANAGEMENT LLC | -20,277 | $0.9900000095367432 |
| 2025-11-28 | MPM BioVentures 2014 (B), L.P. | -20,277 | $0.9900000095367432 |
| 2025-11-28 | MPM ASSET MANAGEMENT LLC | -20,277 | $0.9900000095367432 |
| 2025-11-28 | MPM BioVentures 2014 LLC | -20,277 | $0.9900000095367432 |
| 2025-11-28 | MPM BioVentures 2014, L.P. | -20,277 | $0.9900000095367432 |
| 2025-11-28 | MPM BioVentures 2014 GP LLC | -20,277 | $0.9900000095367432 |
| 2025-12-01 | MPM ASSET MANAGEMENT LLC | -60,917 | $0.9399999976158142 |
| 2025-12-01 | MPM Oncology Innovations Fund GP LLC | -60,917 | $0.9399999976158142 |
| 2025-12-01 | Oncology Impact Fund (Cayman) Management L.P. | -60,917 | $0.9399999976158142 |
| 2025-12-01 | EVNIN LUKE | -39,096 | $0.9399999976158142 |
| 2025-12-01 | MPM BioImpact LLC | -60,917 | $0.9399999976158142 |
| 2025-11-26 | MPM Asset Management Investors BV2014 LLC | -60,733 | $0.9800000190734863 |
| 2025-11-28 | MPM Asset Management Investors BV2014 LLC | -20,277 | $0.9900000095367432 |
| 2025-11-26 | MPM BioVentures 2014, L.P. | -60,733 | $0.9800000190734863 |
| 2025-11-26 | Oncology Impact Fund (Cayman) Management L.P. | -60,733 | $0.9800000190734863 |
| 2025-12-01 | UBS Oncology Impact Fund L.P. | -60,917 | $0.9399999976158142 |
| 2025-11-28 | MPM BioImpact LLC | -20,277 | $0.9900000095367432 |
| 2025-12-01 | Oncology Impact Fund (Cayman) Management L.P. | -60,917 | $0.9399999976158142 |
| 2025-11-28 | MPM Oncology Innovations Fund GP LLC | -20,277 | $0.9900000095367432 |
| 2025-11-26 | MPM ASSET MANAGEMENT LLC | -60,733 | $0.9800000190734863 |
| 2025-11-26 | MPM BioVentures 2014, L.P. | -60,733 | $0.9800000190734863 |
| 2025-12-01 | MPM BioImpact LLC | -60,917 | $0.9399999976158142 |
| 2025-11-28 | MPM ASSET MANAGEMENT LLC | -20,277 | $0.9900000095367432 |
| 2025-11-28 | MPM BioImpact LLC | -20,277 | $0.9900000095367432 |
| 2025-12-01 | GADICKE ANSBERT | -60,917 | $0.9399999976158142 |
| 2025-11-28 | MPM ONCOLOGY INNOVATIONS FUND LP | -20,277 | $0.9900000095367432 |
| 2025-11-28 | MPM ASSET MANAGEMENT LLC | -20,277 | $0.9900000095367432 |
| 2025-11-28 | UBS Oncology Impact Fund L.P. | -20,277 | $0.9900000095367432 |
| 2025-12-01 | MPM ONCOLOGY INNOVATIONS FUND LP | -60,917 | $0.9399999976158142 |
| 2025-12-01 | MPM Oncology Innovations Fund GP LLC | -60,917 | $0.9399999976158142 |
| 2025-11-26 | MPM BioImpact LLC | -60,733 | $0.9800000190734863 |
| 2025-11-26 | MPM ONCOLOGY INNOVATIONS FUND LP | -60,733 | $0.9800000190734863 |
| 2025-11-26 | MPM Oncology Innovations Fund GP LLC | -60,733 | $0.9800000190734863 |
| 2025-11-26 | MPM ASSET MANAGEMENT LLC | -60,733 | $0.9800000190734863 |
| 2025-11-28 | GADICKE ANSBERT | -20,277 | $0.9900000095367432 |
| 2025-11-26 | MPM BioImpact LLC | -60,733 | $0.9800000190734863 |
| 2025-11-28 | MPM ONCOLOGY INNOVATIONS FUND LP | -20,277 | $0.9900000095367432 |
| 2025-12-01 | GADICKE ANSBERT | -60,917 | $0.9399999976158142 |
| 2025-12-01 | MPM ASSET MANAGEMENT LLC | -60,917 | $0.9399999976158142 |
| 2025-11-26 | MPM ASSET MANAGEMENT LLC | -60,733 | $0.9800000190734863 |
| 2025-11-26 | MPM BioVentures 2014 LLC | -60,733 | $0.9800000190734863 |
| 2025-11-28 | GADICKE ANSBERT | -20,277 | $0.9900000095367432 |
| 2025-12-01 | MPM ASSET MANAGEMENT LLC | -60,917 | $0.9399999976158142 |
| 2025-11-26 | GADICKE ANSBERT | -60,733 | $0.9800000190734863 |
| 2025-11-26 | MPM ONCOLOGY INNOVATIONS FUND LP | -60,733 | $0.9800000190734863 |
| 2025-11-26 | UBS Oncology Impact Fund L.P. | -60,733 | $0.9800000190734863 |
| 2025-12-01 | MPM BioImpact LLC | -60,917 | $0.9399999976158142 |
| 2025-12-01 | Oncology Impact Fund (Cayman) Management L.P. | -60,917 | $0.9399999976158142 |
| 2025-12-01 | MPM BioImpact LLC | -60,917 | $0.9399999976158142 |
| 2025-12-01 | GADICKE ANSBERT | -60,917 | $0.9399999976158142 |
| 2025-12-01 | UBS Oncology Impact Fund L.P. | -60,917 | $0.9399999976158142 |
| 2025-12-01 | MPM ASSET MANAGEMENT LLC | -60,917 | $0.9399999976158142 |
| 2025-12-01 | MPM ONCOLOGY INNOVATIONS FUND LP | -60,917 | $0.9399999976158142 |
| 2025-12-01 | MPM Oncology Innovations Fund GP LLC | -60,917 | $0.9399999976158142 |
| 2025-11-26 | MPM BioVentures 2014 (B), L.P. | -60,733 | $0.9800000190734863 |
| 2025-12-01 | MPM Oncology Innovations Fund GP LLC | -60,917 | $0.9399999976158142 |
| 2025-11-28 | Oncology Impact Fund (Cayman) Management L.P. | -20,277 | $0.9900000095367432 |
| 2025-11-28 | MPM BioImpact LLC | -20,277 | $0.9900000095367432 |
| 2025-12-01 | MPM ONCOLOGY INNOVATIONS FUND LP | -60,917 | $0.9399999976158142 |
| 2025-11-28 | UBS Oncology Impact Fund L.P. | -20,277 | $0.9900000095367432 |
| 2025-11-28 | MPM Oncology Innovations Fund GP LLC | -20,277 | $0.9900000095367432 |
| 2025-11-28 | UBS Oncology Impact Fund L.P. | -20,277 | $0.9900000095367432 |
| 2025-11-26 | MPM ASSET MANAGEMENT LLC | -60,733 | $0.9800000190734863 |
| 2025-11-28 | GADICKE ANSBERT | -20,277 | $0.9900000095367432 |
| 2025-11-28 | MPM ONCOLOGY INNOVATIONS FUND LP | -20,277 | $0.9900000095367432 |
| 2025-11-28 | MPM ASSET MANAGEMENT LLC | -20,277 | $0.9900000095367432 |
| 2025-12-01 | Oncology Impact Fund (Cayman) Management L.P. | -60,917 | $0.9399999976158142 |
| 2025-11-26 | Oncology Impact Fund (Cayman) Management L.P. | -60,733 | $0.9800000190734863 |
| 2025-11-26 | MPM BioVentures 2014 GP LLC | -60,733 | $0.9800000190734863 |
| 2025-12-01 | MPM ASSET MANAGEMENT LLC | -60,917 | $0.9399999976158142 |
| 2025-11-26 | MPM BioImpact LLC | -60,733 | $0.9800000190734863 |
| 2025-11-28 | UBS Oncology Impact Fund L.P. | -20,277 | $0.9900000095367432 |
| 2025-11-28 | Oncology Impact Fund (Cayman) Management L.P. | -20,277 | $0.9900000095367432 |
| 2025-11-26 | GADICKE ANSBERT | -60,733 | $0.9800000190734863 |
| 2025-11-28 | MPM ONCOLOGY INNOVATIONS FUND LP | -20,277 | $0.9900000095367432 |
| 2025-11-28 | MPM BioImpact LLC | -20,277 | $0.9900000095367432 |
| 2025-11-26 | MPM Oncology Innovations Fund GP LLC | -60,733 | $0.9800000190734863 |
| 2025-11-26 | MPM Oncology Innovations Fund GP LLC | -60,733 | $0.9800000190734863 |
| 2025-11-26 | MPM ASSET MANAGEMENT LLC | -60,733 | $0.9800000190734863 |
| 2025-11-26 | MPM ONCOLOGY INNOVATIONS FUND LP | -60,733 | $0.9800000190734863 |
| 2025-11-28 | GADICKE ANSBERT | -20,277 | $0.9900000095367432 |
| 2025-11-28 | MPM Oncology Innovations Fund GP LLC | -20,277 | $0.9900000095367432 |
| 2025-11-26 | UBS Oncology Impact Fund L.P. | -60,733 | $0.9800000190734863 |
| 2025-11-26 | Oncology Impact Fund (Cayman) Management L.P. | -60,733 | $0.9800000190734863 |
| 2025-11-26 | UBS Oncology Impact Fund L.P. | -60,733 | $0.9800000190734863 |
| 2025-11-26 | GADICKE ANSBERT | -60,733 | $0.9800000190734863 |
| 2025-11-26 | UBS Oncology Impact Fund L.P. | -60,733 | $0.9800000190734863 |
| 2025-11-26 | Oncology Impact Fund (Cayman) Management L.P. | -60,733 | $0.9800000190734863 |
| 2025-11-26 | MPM BioImpact LLC | -60,733 | $0.9800000190734863 |
| 2025-11-28 | MPM ASSET MANAGEMENT LLC | -20,277 | $0.9900000095367432 |
| 2025-11-26 | UBS Oncology Impact Fund L.P. | -60,733 | $0.9800000190734863 |
| 2025-11-26 | MPM BioVentures 2014 (B), L.P. | -60,733 | $0.9800000190734863 |
| 2025-11-26 | MPM ONCOLOGY INNOVATIONS FUND LP | -60,733 | $0.9800000190734863 |
| 2025-11-28 | Oncology Impact Fund (Cayman) Management L.P. | -20,277 | $0.9900000095367432 |
| 2025-11-26 | GADICKE ANSBERT | -60,733 | $0.9800000190734863 |
| 2025-11-28 | MPM Oncology Innovations Fund GP LLC | -20,277 | $0.9900000095367432 |
| 2025-11-26 | Oncology Impact Fund (Cayman) Management L.P. | -60,733 | $0.9800000190734863 |
| 2025-11-26 | Oncology Impact Fund (Cayman) Management L.P. | -60,733 | $0.9800000190734863 |
| 2025-11-26 | MPM Oncology Innovations Fund GP LLC | -60,733 | $0.9800000190734863 |
| 2025-11-26 | MPM BioImpact LLC | -60,733 | $0.9800000190734863 |
| 2025-11-28 | MPM ONCOLOGY INNOVATIONS FUND LP | -20,277 | $0.9900000095367432 |
| 2025-11-28 | GADICKE ANSBERT | -20,277 | $0.9900000095367432 |
| 2025-11-28 | Oncology Impact Fund (Cayman) Management L.P. | -20,277 | $0.9900000095367432 |
| 2025-11-28 | UBS Oncology Impact Fund L.P. | -20,277 | $0.9900000095367432 |
| 2025-11-26 | GADICKE ANSBERT | -60,733 | $0.9800000190734863 |
| 2025-12-01 | MPM Asset Management Investors BV2014 LLC | -60,917 | $0.9399999976158142 |
| 2025-11-26 | MPM ONCOLOGY INNOVATIONS FUND LP | -60,733 | $0.9800000190734863 |
| 2025-12-01 | UBS Oncology Impact Fund L.P. | -60,917 | $0.9399999976158142 |
| 2025-12-01 | GADICKE ANSBERT | -60,917 | $0.9399999976158142 |
| 2025-11-28 | MPM Asset Management Investors BV2014 LLC | -20,277 | $0.9900000095367432 |
| 2025-12-01 | MPM BioVentures 2014, L.P. | -60,917 | $0.9399999976158142 |
| 2025-11-28 | MPM BioVentures 2014 GP LLC | -20,277 | $0.9900000095367432 |
| 2025-12-01 | MPM BioVentures 2014 (B), L.P. | -60,917 | $0.9399999976158142 |
| 2025-11-28 | MPM BioVentures 2014, L.P. | -20,277 | $0.9900000095367432 |
| 2025-11-28 | MPM BioVentures 2014 (B), L.P. | -20,277 | $0.9900000095367432 |
| 2025-12-01 | MPM BioVentures 2014 LLC | -60,917 | $0.9399999976158142 |
| 2025-11-28 | MPM BioVentures 2014 LLC | -20,277 | $0.9900000095367432 |
| 2025-11-26 | MPM BioVentures 2014 (B), L.P. | -60,733 | $0.9800000190734863 |
| 2025-11-26 | MPM BioVentures 2014 LLC | -60,733 | $0.9800000190734863 |
| 2025-11-26 | MPM BioVentures 2014 GP LLC | -60,733 | $0.9800000190734863 |
| 2025-11-26 | MPM BioVentures 2014, L.P. | -60,733 | $0.9800000190734863 |
| 2025-12-01 | MPM Asset Management Investors BV2014 LLC | -60,917 | $0.9399999976158142 |
| 2025-12-01 | MPM BioVentures 2014 GP LLC | -60,917 | $0.9399999976158142 |
| 2025-11-26 | MPM BioImpact LLC | -60,733 | $0.9800000190734863 |
| 2025-12-01 | MPM BioVentures 2014 LLC | -60,917 | $0.9399999976158142 |
| 2025-11-28 | EVNIN LUKE | -13,014 | $0.9900000095367432 |
| 2025-11-28 | MPM BioImpact LLC | -20,277 | $0.9900000095367432 |
| 2025-11-28 | Oncology Impact Fund (Cayman) Management L.P. | -20,277 | $0.9900000095367432 |
| 2025-12-01 | MPM BioVentures 2014 (B), L.P. | -60,917 | $0.9399999976158142 |
| 2025-12-01 | MPM BioVentures 2014, L.P. | -60,917 | $0.9399999976158142 |
| 2025-11-28 | MPM Asset Management Investors BV2014 LLC | -20,277 | $0.9900000095367432 |
| 2025-12-01 | GADICKE ANSBERT | -60,917 | $0.9399999976158142 |
| 2025-11-26 | MPM Asset Management Investors BV2014 LLC | -60,733 | $0.9800000190734863 |
| 2025-12-01 | MPM BioVentures 2014 GP LLC | -60,917 | $0.9399999976158142 |
| 2025-12-01 | MPM Oncology Innovations Fund GP LLC | -60,917 | $0.9399999976158142 |
| 2025-12-01 | MPM BioImpact LLC | -60,917 | $0.9399999976158142 |
| 2025-12-01 | MPM ONCOLOGY INNOVATIONS FUND LP | -60,917 | $0.9399999976158142 |
| 2025-11-28 | MPM BioVentures 2014 GP LLC | -20,277 | $0.9900000095367432 |
| 2025-11-28 | MPM BioVentures 2014 LLC | -20,277 | $0.9900000095367432 |
| 2025-11-28 | MPM BioVentures 2014 (B), L.P. | -20,277 | $0.9900000095367432 |
| 2025-11-28 | MPM BioVentures 2014, L.P. | -20,277 | $0.9900000095367432 |
| 2025-11-26 | MPM Asset Management Investors BV2014 LLC | -60,733 | $0.9800000190734863 |
| 2025-11-26 | MPM BioVentures 2014 GP LLC | -60,733 | $0.9800000190734863 |
| 2025-11-26 | MPM BioVentures 2014 LLC | -60,733 | $0.9800000190734863 |
| 2025-11-26 | MPM BioVentures 2014 (B), L.P. | -60,733 | $0.9800000190734863 |
| 2025-12-01 | MPM ASSET MANAGEMENT LLC | -60,917 | $0.9399999976158142 |
| 2025-11-26 | MPM BioVentures 2014, L.P. | -60,733 | $0.9800000190734863 |
| 2025-12-01 | MPM ASSET MANAGEMENT LLC | -60,917 | $0.9399999976158142 |
| 2025-12-01 | Oncology Impact Fund (Cayman) Management L.P. | -60,917 | $0.9399999976158142 |
| 2025-12-01 | MPM Oncology Innovations Fund GP LLC | -60,917 | $0.9399999976158142 |
| 2025-12-01 | MPM BioImpact LLC | -60,917 | $0.9399999976158142 |
| 2025-12-01 | UBS Oncology Impact Fund L.P. | -60,917 | $0.9399999976158142 |
| 2025-12-01 | MPM BioImpact LLC | -60,917 | $0.9399999976158142 |
| 2025-12-01 | Oncology Impact Fund (Cayman) Management L.P. | -60,917 | $0.9399999976158142 |
| 2025-12-01 | UBS Oncology Impact Fund L.P. | -60,917 | $0.9399999976158142 |
| 2025-12-01 | MPM ONCOLOGY INNOVATIONS FUND LP | -60,917 | $0.9399999976158142 |
| 2025-12-01 | GADICKE ANSBERT | -60,917 | $0.9399999976158142 |
| 2025-12-01 | MPM ONCOLOGY INNOVATIONS FUND LP | -60,917 | $0.9399999976158142 |
Macro correlation analysis loading...
100% independent. Zero paywalls. Zero subscriptions.
Your support keeps the data flowing.
One-time or recurring — every dollar helps us add more data & features.